NL8601023A - 5-pyrimidinecarboxamiden en behandeling van leukemie en tumoren daarmee. - Google Patents

5-pyrimidinecarboxamiden en behandeling van leukemie en tumoren daarmee. Download PDF

Info

Publication number
NL8601023A
NL8601023A NL8601023A NL8601023A NL8601023A NL 8601023 A NL8601023 A NL 8601023A NL 8601023 A NL8601023 A NL 8601023A NL 8601023 A NL8601023 A NL 8601023A NL 8601023 A NL8601023 A NL 8601023A
Authority
NL
Netherlands
Prior art keywords
pyrimidine carboxamide
pyrimidine
hydroxy
carboxamide
dihydro
Prior art date
Application number
NL8601023A
Other languages
English (en)
Dutch (nl)
Original Assignee
Uniroyal Chem Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chem Co Inc filed Critical Uniroyal Chem Co Inc
Publication of NL8601023A publication Critical patent/NL8601023A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL8601023A 1985-04-22 1986-04-22 5-pyrimidinecarboxamiden en behandeling van leukemie en tumoren daarmee. NL8601023A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/725,736 US4636508A (en) 1985-04-22 1985-04-22 5-pyrimidinecarboxyamides and treatment of leukemia therewith
US72573685 1985-04-22

Publications (1)

Publication Number Publication Date
NL8601023A true NL8601023A (nl) 1986-11-17

Family

ID=24915762

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8601023A NL8601023A (nl) 1985-04-22 1986-04-22 5-pyrimidinecarboxamiden en behandeling van leukemie en tumoren daarmee.

Country Status (21)

Country Link
US (1) US4636508A (xx)
JP (1) JPS6259264A (xx)
CN (2) CN1014990B (xx)
AT (1) AT391864B (xx)
AU (3) AU592559B2 (xx)
BE (1) BE904641A (xx)
CA (1) CA1274509A (xx)
CH (1) CH668970A5 (xx)
DE (1) DE3613447A1 (xx)
DK (1) DK182986A (xx)
ES (3) ES8800671A1 (xx)
FR (1) FR2580642B1 (xx)
GB (1) GB2174391B (xx)
GR (1) GR861024B (xx)
IL (2) IL78576A0 (xx)
IT (1) IT1214499B (xx)
LU (1) LU86403A1 (xx)
NL (1) NL8601023A (xx)
NZ (1) NZ215874A (xx)
SE (1) SE8601826L (xx)
ZA (1) ZA862630B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
FR2628869A1 (xx) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd
FR2628741A1 (fr) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd Nouveaux composes n-phenyl-5-pyrimidinecarboxamides et composition pharmaceutique les contenant utilisable pour induire la regression de la leucemie ou des tumeurs
EP0430885A3 (en) * 1989-12-01 1991-11-06 Ciba-Geigy Ag Anthelmintical compounds
PT1441734E (pt) * 2001-10-26 2007-05-31 Isti Di Ric Di Bio Moleco P An Di-hidroxipirimidinocarboxamidas inibidoras da integrase do vih
US9428466B2 (en) 2013-11-13 2016-08-30 Raymond P. Warrell, Jr. Methods for reducing uric acid levels using barbiturate derivatives
EP3104861A4 (en) * 2014-02-14 2017-10-04 Warrell, Raymond P., Jr. Bifunctional compounds and use for reducing uric acid levels
CN107108526A (zh) 2015-01-22 2017-08-29 R·P·小沃勒尔 双功能化合物及用于降低尿酸水平的用途
TWI772309B (zh) 2016-06-30 2022-08-01 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(二)
DK3481819T3 (da) 2016-07-06 2022-07-25 Acquist Llc Forbindelser og anvendelse deraf til reducering af urisyreniveauer
US11130740B2 (en) 2017-04-25 2021-09-28 Arbutus Biopharma Corporation Substituted 2,3-dihydro-1H-indene analogs and methods using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670756A1 (de) * 1966-10-05 1970-12-23 Hoechst Ag Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
DE2719777A1 (de) * 1976-05-06 1977-11-24 Ciba Geigy Ag Neue 5-phenylcarbamoyl-barbitursaeuren
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
JPS5625166A (en) * 1979-08-09 1981-03-10 Banyu Pharmaceut Co Ltd 5-fluorouracil derivative
JPS5843960A (ja) * 1981-09-10 1983-03-14 Shoichiro Ozaki 5−フルオロウラシル誘導体,その製造法および制ガン剤
DE3347795A1 (de) * 1983-01-14 1985-08-01 Ozaki, Shoichiro, Ehime Neue 1-(n-substituierte carbamoyl)-5-fluorouracil-derivate und krebshemmende mittel, in denen sie als aktive bestandteile enthalten sind
JPS6012322A (ja) * 1983-07-01 1985-01-22 Toyota Motor Corp 四リンク型サスペンシヨン
IL73840A (en) * 1983-12-19 1988-11-15 Uniroyal Chem Co Inc 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU2219588A (en) 1989-01-05
FR2580642B1 (fr) 1988-12-30
AU2219688A (en) 1989-01-05
NZ215874A (en) 1988-09-29
GB2174391A (en) 1986-11-05
DE3613447C2 (xx) 1991-04-11
LU86403A1 (fr) 1987-12-07
DE3613447A1 (de) 1986-10-30
SE8601826L (sv) 1986-10-23
GB2174391B (en) 1988-12-29
IL86711A0 (en) 1988-11-30
CH668970A5 (de) 1989-02-15
ATA101986A (de) 1990-06-15
DK182986D0 (da) 1986-04-21
JPS6259264A (ja) 1987-03-14
SE8601826D0 (sv) 1986-04-21
CN86102767A (zh) 1987-01-07
IL78576A0 (en) 1986-08-31
ES8801220A1 (es) 1988-01-01
ES8800671A1 (es) 1987-11-16
AU592559B2 (en) 1990-01-18
FR2580642A1 (fr) 1986-10-24
CN1038450A (zh) 1990-01-03
GB8609244D0 (en) 1986-05-21
DK182986A (da) 1986-10-23
US4636508A (en) 1987-01-13
IT8620153A0 (it) 1986-04-18
CA1274509A (en) 1990-09-25
IT1214499B (it) 1990-01-18
CN1014990B (zh) 1991-12-04
GR861024B (en) 1986-08-14
ES8801219A1 (es) 1987-12-16
ES554245A0 (es) 1987-11-16
BE904641A (fr) 1986-10-21
ES557683A0 (es) 1987-12-16
ES557684A0 (es) 1988-01-01
AU5641886A (en) 1986-10-30
ZA862630B (en) 1986-11-26
AT391864B (de) 1990-12-10

Similar Documents

Publication Publication Date Title
DE60034240T2 (de) Drogen zur behandlung maligner tumoren
NL8601023A (nl) 5-pyrimidinecarboxamiden en behandeling van leukemie en tumoren daarmee.
EP2277865A1 (en) Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors
US20010023251A1 (en) Guanidine derivatives, processes for preparing them and their use as pharmaceutical compositions
JPH05506240A (ja) 5―ベンジルバルビツレート誘導体
JPH0840892A (ja) 癌細胞に対して活性を有する白金錯体
DE2815724A1 (de) Indolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0073328A1 (en) Novel pyrimidine and s. triazine derivatives with antilipidemic activity
US4634707A (en) 5-Pyrimidinecarboxamides and treatment of leukemia and tumors therewith
EP1083172A1 (en) N-substituted derivatives of 5-oxyiminobarbituric acid
EP0313630B1 (de) Substituierte 2-acylpyridin-alpha-(n)-hetarylhydrazone sowie diese enthaltende arzneimittel
US4587331A (en) Platinum complexes of polyhydroxylated alkylamines and 2-polyhydroxylated alkyl-1,2-diaminoethanes
DE1445127A1 (de) Verfahren zur Herstellung von Pyrazinderivaten
JPS63264580A (ja) 3−(2−ハロアルキル)−1,4−オキサチインおよび2−(2−ハロアルキル)−1,4−ジチイン
DE1965711B2 (de) l^-Dihydro-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0164694B1 (en) N-benzoyl-n'-pyrimidinyloxyphenyl urea compounds, and antitumorous compositions containing them, and process for their preparation
US4920126A (en) Barbituric acid derivative and treatment of leukemia and tumors therewith
Peters et al. Synthesis and tumor-inhibitory properties of 2-methylthio-4-(substituted-anilino)-5-carbethoxypyrimidines
JPH0441145B2 (xx)
DE3730542A1 (de) Arzneimittel mit einem gehalt an bestimmten 6-mercaptopurin-derivaten, verwendung dieser 6-mercaptopurin-derivate, verfahren zur herstellung der arzneimittel sowie einige neue 6-mercaptopurin-derivate und verfahren zu deren herstellung
Pivazyan et al. Ultrasound-assisted green syntheses of novel pyrimidine derivatives and their comparison with conventional methods
DE2439283A1 (de) Neue pyrimidinderivate und verfahren zu deren herstellung
DE3823345A1 (de) 6-merkaptopurin-derivate, ihre herstellung und ihre verwendung zur bekaempfung von retrovirusinfektionen
CA1256861A (en) 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith
JPH0219316A (ja) 白血病治療用薬学的組成物

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BT A notification was added to the application dossier and made available to the public
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed